Answer
Liver-damaging medicines may impair liver function and increase Vyxeos liposomal toxicity by affecting the liver metabolism of daunorubicin; liver function should be monitored more frequently when these medicines are given together.
Sources for this answer
- VyxeosJazz Pharmaceuticals UK Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 15Document updated
Sources checked